Featured Research

from universities, journals, and other organizations

Drug Slows Blindness In AIDS Patients

Date:
March 13, 1997
Source:
Johns Hopkins Medical Institutions
Summary:
AIDS patients facing blindness from a virus infection may respond to the drug cidofovir, according to results of a multicenter study led by a Johns Hopkins researcher.

Office of Communications and Public Affairs

On Line: 76520.560@compuserve.com

Media Contact: Marc Kusinitz 410/955-8665

E-Mail: mkusinit@welchlink.welch.jhu.edu

March 12, 1997

DRUG SLOWS BLINDNESS IN AIDS PATIENTS

AIDS patients facing blindness from a virus infection may respond to the drug cidofovir, according to results of a multicenter study led by a Johns Hopkins researcher.

The drug stops progression of cytomegalovirus (CMV) retinitis, an infection of the light sensitive part of the eye and the major cause of vision loss and blindness in AIDS patients. Unlike traditional treatments that require drug delivery daily through a catheter placed in a central vein, cidofovir is injected into the arm. Central veins are large vessels, for example the jugular vein in the neck, that return blood to the heart. The researchers found that both a low and a high dose of the drug slowed progression of the disease.

"The biggest advantage is that patients receive it only once a week to start and then once every other week," says Douglas Jabs, M.D., professor of ophthalmology and medicine at The Johns Hopkins University School of Medicine. "Other drugs require that a catheter be placed in a vein and left for the duration of treatment."

A previous study by other Hopkins researchers has found that CMV retinitis accounts for 75 percent of AIDS-related CMV disease. The Studies of Ocular Complications of AIDS (SOCA) Research Group, which Jabs chairs, plans to begin another study to compare cidofovir with other drugs now used to treat CMV retinitis.

The study was funded by Gilead Sciences, which manufactures the drug. --JHMI--

Johns Hopkins Medical Institutions news releases can be accessed on-line through the following services:

World Wide Web at http://infonet.welch.jhu.edu/news/news_releases

CompuServe in the SciNews-MedNews library of the Journalism Forum under file extension ".JHM".

JHMI toll-free Health NewsFeed BBS at 1-800-JHH-0046.

Quadnet: send email to: news@quad-net.com. In the body of the message type "info Quadnet."

To enroll in our direct e-mail news release service, call 410-955-4288.


Story Source:

The above story is based on materials provided by Johns Hopkins Medical Institutions. Note: Materials may be edited for content and length.


Cite This Page:

Johns Hopkins Medical Institutions. "Drug Slows Blindness In AIDS Patients." ScienceDaily. ScienceDaily, 13 March 1997. <www.sciencedaily.com/releases/1997/03/970313085434.htm>.
Johns Hopkins Medical Institutions. (1997, March 13). Drug Slows Blindness In AIDS Patients. ScienceDaily. Retrieved October 21, 2014 from www.sciencedaily.com/releases/1997/03/970313085434.htm
Johns Hopkins Medical Institutions. "Drug Slows Blindness In AIDS Patients." ScienceDaily. www.sciencedaily.com/releases/1997/03/970313085434.htm (accessed October 21, 2014).

Share This



More Health & Medicine News

Tuesday, October 21, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

How Nigeria Beat Its Ebola Outbreak

How Nigeria Beat Its Ebola Outbreak

Newsy (Oct. 20, 2014) The World Health Organization has declared Nigeria free of Ebola. Health experts credit a bit of luck and the government's initial response. Video provided by Newsy
Powered by NewsLook.com
Another Study Suggests Viagra Is Good For The Heart

Another Study Suggests Viagra Is Good For The Heart

Newsy (Oct. 20, 2014) An ingredient in erectile-dysfunction medications such as Viagra could improve heart function. Perhaps not surprising, given Viagra's history. Video provided by Newsy
Powered by NewsLook.com
Ebola Worries End for Dozens on U.S. Watch Lists

Ebola Worries End for Dozens on U.S. Watch Lists

Reuters - US Online Video (Oct. 20, 2014) Forty-three people who had contact with Thomas Eric Duncan, the first person diagnosed with Ebola in the U.S., were cleared overnight of twice-daily monitoring after 21 days of showing no symptoms. Rough Cut (no reporter narration). Video provided by Reuters
Powered by NewsLook.com
CDC Calls for New Ebola Safety Guidelines

CDC Calls for New Ebola Safety Guidelines

AP (Oct. 20, 2014) Centers for Disease Control and Prevention Director Dr. Tom Frieden laid out new guidelines for health care workers when dealing with the deadly Ebola virus including new precautions when taking off personal protective equipment. (Oct. 20) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins